1 of 42

Therapeutic Effects

Unit 1 Lesson 2.3

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

2 of 42

COPYRIGHT

© 2013-2025 Nurses International (NI). All rights reserved. No copying without permission. Members of the Academic Network share full proprietary rights while membership is maintained.

NI Privacy Policy and Terms of Use.

Contact info: info@nursesinternational.org

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

3 of 42

Student Learning Outcomes

  • Define Therapeutic Window, Peak, Trough, and Therapeutic Index
  • Describe therapeutic blood level testing and evaluation of drugs
  • Discuss the nurse’s role in evaluating medications

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

4 of 42

Therapeutic Window 1

  • The range of drug dosage between the minimally effective dose (Effective Concentration) and the toxic dose (Toxic Concentration)
  • The "perfect dose" where the desired therapeutic effect is achieved without causing toxicity

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

5 of 42

Therapeutic Window 2

  • Example:
    • Warfarin's therapeutic window is monitored using the International Normalized Ratio (INR) blood test to prevent clotting and bleeding
  • INR range
    • 2.0 - 3.0 for most indications, 2.5 - 3.5 for mechanical heart valves

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

6 of 42

Peak and Trough Levels 1

  • Peak level
    • Highest drug concentration in the bloodstream after administration
  • Typically obtained between 30 minutes and 2 hours after drug administration (depends on drug pharmacokinetics)
  • Trough level
    • Lowest drug concentration in the bloodstream before the next dose
  • Typically measured just before the next dose (within 30 minutes of the next scheduled dose)

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

7 of 42

Peak and Trough Levels 2

  • Medications have predicted reference ranges for peak and trough levels
  • Nurses must plan the administration of IV medications according to the timing of blood draws for peak and trough levels
  • Example
    • Gentamicin requires peak and trough levels to monitor nephrotoxicity and ototoxicity

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

8 of 42

Peak and Trough Levels 3

  • Peak level
    • 5-10 mcg/mL (30 minutes after completion of a 30-minute infusion)
  • Trough level
    • < 2 mcg/mL (within 30 minutes before the next dose)

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

9 of 42

Interpreting Peak and Trough Levels 1

  • Peak levels above the therapeutic range may indicate toxicity and require dose reduction
  • Peak levels below the therapeutic range may indicate inadequate dosing and require dose increase

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

10 of 42

Interpreting Peak and Trough Levels 2

  • Trough levels above the therapeutic range may indicate accumulation and require dose reduction or increased dosing interval
  • Trough levels below the therapeutic range may indicate inadequate dosing and require dose increase or decreased dosing interval

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

11 of 42

Critical Thinking Question

A client is receiving gentamicin for a severe infection. The nurse is reviewing the client's peak and trough levels. Which result would indicate that the gentamicin dose needs to be adjusted?

  1. Peak: 6 mcg/mL, Trough: 1.5 mcg/mL
  2. Peak: 8 mcg/mL, Trough: 1.8 mcg/mL
  3. Peak: 12 mcg/mL, Trough: 3 mcg/mL
  4. Peak: 9 mcg/mL, Trough: 1 mcg/mL

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

12 of 42

Therapeutic Index 1

  • Quantitative measurement of the relative safety of a drug
  • Compares the amount of drug that produces a therapeutic effect versus a toxic effect
  • A high therapeutic index indicates a wide margin of safety, as the toxic dose is much higher than the therapeutic dose
  • A low therapeutic index indicates a narrow margin of safety, as the toxic dose is close to the therapeutic dose

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

13 of 42

Therapeutic Index 2

  • High therapeutic index
    • Wide therapeutic window, relatively safe drug
  • Low therapeutic index
    • Narrow therapeutic window, dosage titrated according to blood levels

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

14 of 42

Therapeutic Index 3

  • Example
    • Phenytoin has a narrow therapeutic index and requires frequent peak and trough drug level monitoring
  • Therapeutic range
    • 10 - 20 mcg/mL
  • Toxic level
    • > 30 mcg/mL
  • Subtherapeutic level
    • < 10 mcg/mL (increased risk of seizures)

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

15 of 42

Critical Thinking Question

A client with epilepsy is prescribed phenytoin. The nurse is reviewing the client's phenytoin levels and notes that the most recent level is 8 mcg/mL. What is the most appropriate nursing action?

  1. Continue the current phenytoin dose
  2. Increase the phenytoin dose
  3. Decrease the phenytoin dose
  4. Stop the phenytoin and notify the provider

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

16 of 42

Therapeutic Drug Monitoring 1

  • Involves measuring drug concentrations in the blood to optimize therapy
  • Used for drugs with a narrow therapeutic index or high variability in client response
  • Peak levels are measured shortly after a dose to assess the maximum concentration

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

17 of 42

Therapeutic Drug Monitoring 2

  • Trough levels are measured just before the next dose to assess the minimum concentration
  • Nurses should be familiar with the therapeutic range for monitored drugs and alert the healthcare team if levels are outside this range

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

18 of 42

Comparison of Drugs with Broad and Narrow Therapeutic Indexes

Drug

Therapeutic Index

Therapeutic Range

Amoxicillin

Broad

N/A

Warfarin

Narrow

INR 2.0 - 3.0

Digoxin

Narrow

0.5 - 2.0 ng/mL

Acetaminophen

Broad

N/A

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

19 of 42

The Nurse's Role in Therapeutic Drug Monitoring

  • Understand the reasons for therapeutic drug monitoring and the drugs that commonly require it
  • Collect peak and trough levels as appropriate
  • Interpret the results in the context of the client’s clinical condition
  • Collaborate with the healthcare team to adjust medication doses as appropriate
  • Monitor the client for signs of toxicity or inadequate therapeutic response

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

20 of 42

Evaluating the Effects of Medications

  • Dosages should be verified to ensure they are within recommended safe ranges and potency
  • Potency
    • The amount of drug required to produce the desired effect
  • Selectivity
    • The separation between the desired and undesired effects of a drug

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

21 of 42

Drug Selectivity Targeting Specific Cellular Pathways 1

  • Drug selectivity
    • The ability of a drug to specifically target a desired receptor, enzyme, or cellular process
  • Highly selective drugs interact only with their intended biological target, reducing off-target effects and adverse reactions
  • Less selective drugs may affect multiple targets
    • Increases the risk of side effects

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

22 of 42

Drug Selectivity Targeting Specific Cellular Pathways 2

  • Example
    • Beta-blockers selectively block beta-1 adrenoceptors in the heart, while minimizing effects on beta-2 receptors in the lungs
  • Clinical relevance
    • High selectivity → Fewer side effects and safer pharmacological profile
    • Low selectivity → Higher risk of adverse effects due to off-target interactions

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

23 of 42

Drug Potency: How Much Drug is Needed to Achieve an Effect? 1

  • Potency
    • The amount of drug needed to produce a specific therapeutic effect
  • Highly potent drugs require a lower dose to achieve the desired effect
  • Less potent drugs require higher doses for the same effect

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

24 of 42

Drug Potency: How Much Drug is Needed to Achieve an Effect? 2

  • Example
    • Fentanyl (highly potent opioid) → Effective at microgram doses
    • Morphine (less potent opioid) → Requires a higher milligram dose for the same level of pain relief
  • Clinical relevance
    • Higher potency does not mean greater efficacy; some potent drugs have serious side effects
    • Potency affects dosing considerations, risk of toxicity, and client response

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

25 of 42

Common Medications Requiring Blood Level Monitoring

  • Lithium (bipolar disorder)
    • Therapeutic range 0.6 - 1.2 mEq/L, toxic > 1.5 mEq/L
  • Digoxin (heart failure)
    • Therapeutic range 0.5 - 2.0 ng/ml, toxic > 2.5 ng/ml
  • Vancomycin (antibiotic)
    • Trough level 10 - 20 mcg/mL, peak level not routinely measured
  • Theophylline (asthma, COPD)
    • Therapeutic range 10 - 20 mcg/mL, toxic > 20 mcg/mL

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

26 of 42

Critical Thinking Question

A client is prescribed digoxin for heart failure. The nurse is monitoring the client's digoxin levels and notes that the most recent level is 2.8 ng/mL.

What actions should the nurse take based on this information?

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

27 of 42

Factors Affecting Therapeutic Levels 1

  • Liver function
    • Impaired liver function can lead to drug accumulation and toxicity
  • Kidney function
    • Impaired renal function can lead to drug accumulation and toxicity
  • Age
    • Elderly clients may have reduced drug clearance and require lower doses

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

28 of 42

Factors Affecting Therapeutic Levels 2

  • Hydration status
    • Dehydration can lead to increased drug concentrations
  • Genetic variations in metabolism
    • Some clients may be poor or rapid metabolizers of certain drugs

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

29 of 42

Genetic Variability in Drug Metabolism 1

  • Some drugs (e.g., clopidogrel, codeine, warfarin) require genetic testing due to variations in metabolism
  • Differences in CYP450 enzyme metabolism affect drug efficacy and toxicity
  • Poor metabolizers
    • Reduced enzyme activity, higher risk of toxicity at standard doses

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

30 of 42

Genetic Variability in Drug Metabolism 2

  • Rapid metabolizers
    • Increased enzyme activity, may require higher doses for therapeutic effect
  • Example
    • Codeine is metabolized by CYP2D6 to its active form, morphine
    • Poor metabolizers may not achieve adequate pain relief
    • Rapid metabolizers may experience opioid toxicity at standard doses

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

31 of 42

Nursing Considerations for Medications Requiring Blood Level Monitoring

  • Monitor renal function (creatinine, GFR), hydration status, and electrolyte levels (potassium, sodium)
  • Assess for signs and symptoms of toxicity
    • Example: nausea, vomiting, diarrhea, dizziness, confusion
  • Collaborate with pharmacists and providers to adjust doses based on lab results and clinical status

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

32 of 42

Critical Thinking Question

A client is admitted to the hospital with a severe infection and is started on intravenous vancomycin. The client's vancomycin trough level is 8 mcg/mL. The nurse notes that the client's serum creatinine has increased from 1.0 mg/dL to 1.8 mg/dL since starting vancomycin therapy.

What should the nurse consider, and what actions should be taken?

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

33 of 42

Side Effects vs. Adverse Effects 1

  • Side effects
    • Unintended but generally anticipated effects other than the intended effect
    • Example: nausea, vomiting, diarrhea, drowsiness
  • Adverse effects
    • Relatively unpredictable, severe, and harmful effects that require discontinuation of the medication

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

34 of 42

Side Effects vs. Adverse Effects 2

  • Example
    • An adverse effect to Ciprofloxacin is tendon rupture
  • Adverse effects should be reported to the pharmacy and tracked as a client safety concern

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

35 of 42

The Nurse's Role in Evaluating Medications: Assessment

  • Pre-administration assessment
    • Review client history
    • Renal/liver function
    • Drug interactions
  • Assess for contraindications and precautions
  • Obtain baseline vital signs and lab values

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

36 of 42

The Nurse's Role in Evaluating Medications: Monitoring

  • Check therapeutic drug levels according to the recommended schedule
  • Assess for signs and symptoms of toxicity
    • Example: nausea, arrhythmias in case of digoxin toxicity
  • Monitor for side effects and adverse reactions

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

37 of 42

The Nurse's Role in Evaluating Medications: Evaluation

  • Evaluate the effectiveness of the medication in treating the underlying condition
  • Assess for any changes in the client’s clinical status or lab values
  • Determine if the medication dose needs to be adjusted or discontinued

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

38 of 42

The Nurse's Role in Evaluating Medications: Intervention

  • Stop medication if drug levels are too high and notify the provider
  • Administer medications to manage side effects
    • Example: antiemetics for nausea
  • Implement interventions to prevent or manage adverse effects
    • Example: fall precautions for clients experiencing dizziness

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

39 of 42

The Nurse's Role in Evaluating Medications: Education

  • Explain the purpose of the medication and how it works
  • Educate clients on the importance of adhering to the prescribed dosing schedule
  • Teach clients how to recognize and report signs of toxicity
    • Example: Blurred vision in case of digoxin toxicity
  • Provide information on lifestyle modifications that can enhance the effectiveness of the medication
    • Example: Diet, exercise

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

40 of 42

The Nurse's Role in Evaluating Medications: Collaboration

  • Coordinate with pharmacists and providers to adjust doses based on lab results and clinical status
  • Participate in interdisciplinary rounds to discuss the client’s response to medication therapy
  • Communicate any concerns or changes in the client’s condition to the healthcare team

(Ernstmeyer & Christman, 2023)

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

41 of 42

References

Ernstmeyer, K. & Christman, E. (2023). Open RN Nursing Pharmacology. Open RN. https://wtcs.pressbooks.pub/pharmacology2e/

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

42 of 42

Please go to

My Learning Experience

to provide feedback on your experience.

Thank you, and come back soon!

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.

© 2013-2024 Nurses International (NI).

Contact info: info@nursesinternational.org

© 2013-2025 Nurses International (NI) and the Academic Network. All rights reserved.